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Abstract
Background: The susceptibility of mice and humans to Chandipura virus infection is age-dependent. Upon
experimental infection, mice secrete significant amounts of proinflammatory cytokines. Similarly, children who
recover from natural infection with the virus show significant amounts of TNF-α production, suggesting that innate
immunity plays a major role in the response to Chandipura virus. Toll-like receptors (TLR) are key host molecules
involved in innate immune responses in infections. Therefore, the aim of this study was to examine the role of TLR
in the response to Chandipura virus infection.
Methods: The mouse monocyte-macrophage cell line, RAW 264.7, and C3H/HeJ mice were used as models. Micro
array techniques were used to identify the type of TLR involved in the response to infection. The results were
validated by examining TLR expression using flow cytometry and by measuring the levels of proinflammatory
cytokines and nitric oxide (NO) in the culture supernatants using bead assays and the Griess method, respectively.
The pathogenic role of Toll-like receptor 4 (TLR4) was studied in a TLR4 mutant strain of mice -C3H/HeJ and the
results compared with those from wild-type mice- C3H/CaJ. The pathogenic effects of NO were studied by treating
experimentally infected mice with the NO inhibitor, aminoguanidine (AG).
Results: The micro array results showed that TLR4 was regulated after Chandipura virus infection. At high
multiplicities of infection (10 MOI), RAW cells up- regulated cell surface expression of TLR4 and secreted significant
amounts of TNF-α, MCP-1, IL-10 and IL-12 and NO. The survival rate of C3H/HeJ mice was higher than those of
wild-type C3H/CaJ mice. The survived C3H/HeJ mice secreted significant quantity of MCP-1 and IFN-γ cytokines and
cleared virus from brain. Similarly, the survival rate of AG-treated mice was higher than those of the untreated
controls.
Conclusions: Chandipura virus regulates TLR4, which leads to the secretion of proinflammatory cytokines and NO
by infected RAW cells. Difference in survival rate in TLR4 mutant mice and nitric oxide inhibitor treated mice,
confirmed the role of these molecules in disease pathogenesis. The result is significant in clinical management and
designing antiviral intervention for Chandipura virus infection.
Background
Chandipura virus (CHPV) belonging to the family Rhab-
dovirdae, genus vesiculovirus has been associated with
acute and fatal encephalitis of young children in several
parts of India [1,2]. Children under 15 years of age are
vulnerable to natural infection, whereas adults are re-
fractory. Similarly, susceptibility studies in mice show
that CHPV is lethal to young mice, but adults are only
susceptible through the intra-cerebral route of infection
[3]. This age-dependent susceptibility is also apparent in
nude mice [4]. Further, virus-infected young mice se-
crete significant amounts of proinflammatory cytokines
[5] and children who have recovered from natural infec-
tions secrete significant levels of TNF-α [6]. Taken, to-
gether, these observations strongly suggest that innate
immunity plays a pivotal role in protection from CHPV
infection. The role of innate immunity is critical during
early childhood, particularly when humoral and cell
mediated immune responses are not fully developed.
Innate immunity is mediated by several mechanisms.
Toll-like receptors (TLR) are key host molecules
involved in innate immune responses to infection [7].
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TLRs were first identified in Drosophila. To date, 13
mammalian TLRs have been identified [8]. Toll path-
ways are known to respond to Gram positive bacterial
and fungal infections, and are essential for anti-viral im-
munity [9]. In humans, TLR1, TLR2, TLR4, TLR5 and
TLR6 are cell membrane-associated, and respond pri-
marily to bacterial surface-related pathogen associated
molecular patterns (PAMPs). A second group, compris-
ing TLR3, TLR7, TLR8 and TLR9, is found on the sur-
faces of endosomes, and responds primarily to nucleic
acid-based PAMPs derived from viruses and bacteria.
The interaction between TLRs and viral ligands leads to
the secretion of both proinflammatory cytokines, type I
interferons and nitric oxide (NO) [10,11]. Recent studies
also show that several types of neural tissue cell up-
regulate particular TLRs in response to infection [12].
Failure to prevent or control TLR response could lead to
exuberant induction of detrimental cytokines. Various
experimental mice model suggests that TLR activation
promotes protective antiviral immunity in some cases,
while exacerbating disease in others [13]. A role of dif-
ferent TLRs in the response to viruses has been estab-
lished [14-19].
A growing body of evidence indicates that one particu-
lar product of the innate immune response, NO, or its
derivatives, has inhibitory effects against a variety of viral
infections. NO is one of the products of TLR4 stimula-
tion [20]. Nitric oxide synthase (iNOs) mutant mice are
more vulnerable to some types of infection than wild-
type mice [21]. NO hinders the productive infection of
several animal viruses, including herpes simplex virus 1
(HSV1) [22], ectromelia virus, vaccinia virus (VV) [23],
vesicular stomatitis virus (VSV) [24] and murine
leukemic virus (MLV) [25]. This suggests that NO could
be one of the vital factors that enable host innate im-
mune responses to control the initial stages of viral
infections within the central nervous system. NO plays a
role in host defense mechanisms due to its antibacterial
and virustatic properties; however, if NO synthesis is not
properly regulated, damage of host cells occurs due to
its inherent cytotoxicity [26].
In the present study, we focused on the types of TLR
involved in immune responses to CHPV infection using
RAW cells as an in vitro model. The role of TLRs in dis-
ease pathogenesis is also investigated in mice. The
results identify a role for TLR4 in the response to CHPV
infection and its role in disease pathogenesis.
Methods
Cells and virus
Vero E6 and RAW 264.7 cell lines were obtained from
the National Centre for Cell Science, Pune, India. The
cell lines were cultured and maintained in Dulbecco’s
modified Eagle’s medium (DMEM), supplemented with
10% fetal calf serum (FCS, Gibco) and antibiotics. The
Chandipura virus strain (034267) was originally isolated
from the CHPV outbreak in Andhra Pradesh in 2003
[2]. The virus was propagated and titrated in vero E6
cells.
Viral infection
Confluent monolayer of RAW cells (106 cells) was
infected with CHPV at 107 50% tissue culture infective
dose per mL (TCID50/mL). After adsorption for 1- h at
37°C, the cells were washed with PBS and incubated
with DMEM for 24 h at 37°C with 5% CO2. Triplicate
cultures were harvested at various times from 1 to 24 h
post infection (PI); centrifuged for 5 min at 2500 xg, and
virus concentration was determined by endpoint dilu-
tions assay. The titer was calculated by the method of
Reed and Muench [27].
Microarray analysis
Total RNA was isolated from control and infected RAW
cells at 5 h PI using an RNeasy mini kit (Qiagen). The
quality and integrity of the RNA was checked before la-
beling using a 2100 Bioanalyzer (Agilent). RNA was la-
beled by using Agilent Low RNA Input Linear
Amplification kit. Hybridization was performed on
mouse microarray slides with 22000 prints (G4112A,
Agilent). The biological repeat was performed on the
same samples. Data were collected from the hybridized
slides using GeneSpring GX 7.2 software and normalized
using by Per Spot and Per Chip intensity dependent
(Lowess) normalization. Up-regulated genes (ratio> 2)
and down-regulated genes (ratio< 0.5) were used to cal-
culate -fold changes. Genes showing -fold changes (log2)
> 1 (for up-regulated genes) and>−1 (for down-regu-
lated genes) were further analyzed. The significant func-
tional classification of differentially regulated genes was
analyzed using the GeneSpring GX 7.2 software ontology
browser and differentially regulated genes significantly (P
< 0.05) contributing to the pathways was identified. All
data were MIAME-compliant and the raw data has been
submitted to Gene Expression Omnibus (GEO -NCBI,
Acc.No.GSE 13082).
TLR4 expression
Cell culture dishes containing confluent monolayer of
RAW cells were divided into three groups. The first
group was treated with different concentrations of LPS
(0–1000 ng/dish). The second group was infected with
different MOI of virus (10, 1, or 0.1). The third group
was used as uninfected control. All dishes were incu-
bated for 24 h at 37°C with 5% CO2. The cells were then
washed with PBS and scraped. Single cell suspensions
were produced by slow pipetting, and the cells were pel-
leted by centrifugation at 300 ×g for 10 min. One
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million cells were suspended in 100 μL of FACS staining
buffer (PBS pH 7.2, 2% FCS, 0.09% sodium azide, 1%
mouse serum) and stained with an anti mouse TLR4/
MD2 antibody conjugated to phycoerythrin-cyanine 7
(PE-Cy7) (eBioscience). Appropriate isotype controls
were included to set the base line data. After 1-h incuba-
tion at 4°C, the cells were washed thrice with staining
buffer and the pellet suspended in 500 μL of 1% parafor-
maldehyde. The cells were acquired and analyzed using
a FACSCalibur cell sorter and Cell Quest Pro software
(BD Bioscience).
Half-offset histograms were prepared using Flow Jo
software (Tree Star, USA).
Quantification of mouse inflammatory cytokines
The levels of IL-12p70, TNF-α, IFN-γ, MCP-1, IL-10 and
IL-6 in the cell culture supernatants were quantified using
a BD™ Cytometric Bead Array (CBA) mouse inflammation
kit (BD Biosciences). The minimum/maximum sensitivity
of this assay is 0–5000 pg/mL. The levels of the six cyto-
kines were measured simultaneously in 50 μL of undiluted
culture supernatant and expressed as pg/ml.
Mice experiments
The pathogenicity study was conducted in C3H/HeJ and
C3H/CaJ mice. Groups of mice (13-days-old) were used in
this experiment (n=8, plus the mother per group). The
experimental procedure was followed as per the
recommendations of the Committee for the Purpose of
Control and Supervision on Experiments on Animals
(CPCESA), India and the protocol was approved by the In-
stitute Animal Ethics Committee (IAEC), National Institute
of Virology, Pune. All efforts were made to minimize
suffering. Both C3H/HeJ and C3H/CaJ mice were infected
with 100 μL (105 TCID50/mL) of CHPV via the subcutane-
ous route. The mice were observed for sickness and mortal-
ity up to 10 days PI. Blood and brain was collected at 0, 24,
48, 72 and 96 h PI. Blood was collected intra orbitally be-
fore sacrifice and the sera were separated. Mice were per-
fused transcardially with 20 mL of PBS and the brain was
collected and frozen immediately at −80°C. Before use, the
frozen brain was freeze thawed and 10% homogenate pre-
pared in PBS. The suspension was clarified at 1000 ×g for
10 min and the virus in the supernatant was titrated. Cyto-
metric bead array was performed from 50 μL of undiluted
serum.
IgM kinetics
IgM capture ELISA was done following procedure
described for human [2] with the modification that coat-
ing was done with anti-mouse IgM as a capture anti-
body. The level of IgM was determined from 1/100
diluted samples. The cut off value was set by average
plus 3 standard deviation of optical density (OD) from
uninfected negative control mice.
Quantification of nitric oxide
The cells were infected with different MOI (0.1, 1, and
10 MOI) of virus and the supernatants harvested at 24 h
PI. NO levels were measured using the Griess method
[28]. Briefly, 100 μL of Griess reagent (1% sulfanilamide,
0.1% naphthylethylene diamine dihydrochloride, 2.5%
H3PO4) was added to 100 μL of cell supernatant in a 96-
well plate. The colorimetric reaction was allowed to
proceed for 10 min at room temperature and the OD at
540 nm (with a reference wavelength of 655 nm) was
measured in a micro plate reader (Model 680 XR,
BioRad). The measured OD values were converted to




















Figure 1 One-step growth cycle of Chandipura virus in RAW
cells. RAW cells were infected with virus. At different time points,
the culture supernatants were collected for virus titration. The
supernatant was titrated in vero E6 cells and the titer was expressed
as log10 tissue culture infective dose 50% (TCID50) per 100 μL. The
line graph is showing virus titer up-to 12 h PI and the titer was
remained same at other PI hours tested.
Table 1 Genes involved in different signaling pathways
within Chandipura virus infected RAW cells
Path ways involving up-regulated genes P-value
Toll-like receptor signaling pathway 6.02E-12
Cytokine-cytokine receptor interaction 2.65E-08
MAPK signaling pathway 6.78E-06
Antigen processing and presentation 0.00175
Jak-STAT signaling pathway 0.00189
T cell receptor signaling pathway 0.00859
Path ways involving down-regulated genes
Selenoamino acid metabolism 0.0257
Galactose metabolism 0.0291
Chondroitin sulfate biosynthesis 0.0345
Insulin signaling pathway 0.0375
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established from serial dilutions of sodium nitrite
(NaNO2) in culture medium. All the samples were
assayed in triplicate.
NO inhibitor treatment
Swiss albino mice (13-days-old) were divided into two
groups (n= 8, plus the mother per group). Both the
Figure 2 Flow chart showing the genes involved in TLR signaling pathway. In the TLRs signaling path way chart, genes highlighted in red















Figure 3 Analysis of membrane expression of TLR4 in RAW cells. RAW cells were infected with different MOI of Chandipura virus. In a
second set of experiments, the cells were treated with different concentration of LPS. The cells were incubated for overnight at 37°C. The cells
were then stained with an anti-mouse TLR4- PE-Cy7 conjugate and analyzed by flow cytometry. Half-offset histogram of mean fluorescent
intensity of (A) RAW cells infected with Chandipura virus. (B) RAW cells treated with LPS.
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groups of mice were infected with 100 μL (105 TCID50/
mL) of CHPV via the subcutaneous route. One group
was injected with 100 μL (100 mg/kg body weight) of
aminoguanidine (AG), and the other was used as a virus
control.Treatment started at 24 h PI and continued up
to 120 h PI. The mortality pattern was recorded and the
percentage mortality calculated.
Statistical analysis
The Student t test was used to compare the means values
for the treated and control groups. A P value< 0.05 was
considered significant. The mean survival time was
calculated using Kaplan Meier statistics for survival
function (GraphPad prism 5 and PASW Statistics 18
software).
Results
One-step growth cycle of CHPV
RAW 264.7 cells were used to identify the type of TLR
involved in the immune response to CHPV infection.
Initially, the susceptibility of this cell line to CHPV was
confirmed using a one-step growth cycle. Infected RAW
cells produced detectable levels of virions from 4 h PI,
and the maximum titer was observed at 8 h PI
(Figure 1).
Regulation of TLR4 by CHPV
Gene regulation in RAW 264.7 cells during infection
was studied using microarray techniques. The results
indicated that several genes were up-regulated, and that
the up-regulated genes were involved in TLR pathways,
cytokine-cytokine receptor interactions, and the MAPK
pathway (Table 1). Interestingly, up-regulated TLR genes
were mainly involved in the TLR4 pathway (Figure 2).
The up-regulation of TLR4 during infection was further
validated in experiments studying regulation of mem-
brane expression of TLR4 and secretion of proinflam-
matory cytokines in infected RAW cells. In this
experiment LPS, a known activator of TLR4, was used
as the positive control. RAW cells up-regulated TLR4
expression after infection with virus at 10 and 1.0 MOI,
but down-regulated with 0.1 MOI (Figure 3A). Upon
LPS treatment, the cells down-regulated TLR4 expres-
sion at all concentrations used in the experiment (Fig-
ure 3B). In the second experiment, the downstream
signaling products of TLR4 (proinflammatory cytokines)
were measured. Signature proinflammatory cytokines
such as TNF-α, MCP-1, IL-12, IL-10, IFN-γ and IL-6
were measured in the supernatants of virus infected
cells. Uninfected cell culture supernatants were used as
control. Detectable levels of TNF-α and MCP-1 were
observed 2 h PI (130 and 206 pg/mL, respectively) and
reached a maximum at 10 h PI (3759 and 1348 pg/mL,
respectively). IL-10 levels peaked at 4 h PI, and then
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Figure 4 Proinflammatory cytokine levels in culture
supernatants of Chandipura virus-infected RAW cells. RAW cells
were infected with virus. The supernatant was collected on alternate
hours up to 10 h PI. The final sample was collected 16 h PI. The
levels of TNF-α, MCP-1, IL-10, IL-6, IL-12 and IFN-γ in the undiluted
supernatant were quantified using a cytometric bead assay. The
beads were acquired and analyzed using a FACSCalibur cell sorter
and BD™ Cytometric Bead Array Software (BD Bioscience). The level
of cytokines was quantified using known standard supplied with kit.
Values represent the mean + standard error (SE) of triplicate
experiments. IFN-γ could not be detected in the samples.
Figure 5 Survival of virus-infected C3H/HeJ and C3H/CaJ mice.
Mice were infected with Chandipura virus. The infected mice were
observed up to 13 days PI. The percent survival was calculated using
Kaplan-Meier statistics and GraphPad Prism 5 software. Significantly
improved survival rates were observed in C3H/HeJ mice (P< 0.000).
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behavior was noticed with respect to IL-12 secretion.
The level peaked at 2, 6, and 10 h PI and reached
baseline at 4 and 8 h PI (Figure 4). No differences in
IL-6 levels were observed. Similarly, no IFN-γ could be
detected.
TLR4 in disease pathogenesis
To explore the possibility that TLR4 is involved in dis-
ease pathogenesis, wild-type C3H/CaJ mice and TLR4
mutant C3H/HeJ mice were infected with CHPV. Mean
survival time and survival rate was calculated. Proin-
flammatory cytokines, virus specific IgM and virus titer
was measured in these mice. The mean survival time
was higher in C3H/HeJ mice (208.5 ± 4.6 h) than those
in C3H/CaJ mice (160.5 ± 11.56 h). Similarly, the mean
survival rate of C3H/HeJ mice was significantly higher
than that of wild-type C3H/CaJ mice (86% vs 31.25%, P
< 0.000; Figure 5). Gradual increase in virus specific IgM
level was observed in both mutant and wild-type mice.
However, no significant difference in IgM level was
noticed between these groups (Figure 6). The virus titer
in brain was gradually increased from 104 at 48 h PI to
107 TCID50/mL at 96 h PI in C3H/CaJ mice. Titration
was not done beyond 96 h PI as mortality started at this
time point. In contrast, in C3H/HeJ mice, the virus titer
was 104 TCID50/mL at 72 h PI and reached undetectable
level at 120 h PI (Figure 7). In blood, the virus titer was
101 TCID50/mL at 24 h PI and it was undetectable level
in all other PI hours tested. The level of MCP-1 and
IFN-γ cytokines was significantly higher in infected
C3H/HeJ mice than those in infected C3H/CaJ mice.
The level of MCP-1 in C3H/HeJ mice (726 ± 122 pg/mL)
at 24 h PI was greater than that in C3H/CaJ mice
(50 ± 9.6 pg/mL). Similarly, IFN-γ level was higher in
C3H/HeJ mice (59 ± 17 pg/mL) than that in C3H/CaJ
mice (19 ± 3.9 pg/mL) (Figure 8). Significant level of dif-
ference in quantity was not observed in other cytokines
(IL-12, IL-6, IL-10, TNF-α) tested.
Nitric oxide in disease pathogenesis
CHPV infected RAW cells secreted NO and NO level
was higher at 1.0 MOI (31 μM) than at 10 MOI (10 μM)
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Figure 6 Chandipura specific IgM in sera of infected C3H/HeJ and C3H/CaJ mice. The level of IgM in the sera was determined by mouse
IgM capture ELISA. The values are optical density (OD) at 490 nm wave length. The serum from three mice of infected as well as uninfected mice
from C3H/HeJ and C3H/CaJ mice was processed separately in each time points. The values are Mean ± SE of three mice. Cut off value derived
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Figure 7 Virus titer in blood and brain from infected C3H/HeJ
and C3H/CaJ mice. The sera and brain suspensions from three
mice of C3H/HeJ as well as C3H/CaJ mice were titrated in vero E6
cells. Virus concentration was determined by end point dilution
assay and reciprocal of highest dilution which showing 50% cell lysis
was considered end point. The TCID50 per 100 μL was calculated by
Reed and Munch formula. Each point in line graph represents mean
virus titer of three mice.
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and uninfected cell culture supernatants. To ascertain
the role of NO in disease pathogenesis, virus infected
Swiss albino mice were treated with the NO inhibitor,
AG. Partial protection was observed in AG-treated mice
(62%) as compared to that in AG untreated mice (42%).
The mean survival time for AG treated group (203 ± 7 h)
was significantly higher than control group (180 ± 7 h; P
< 0.05; Figure 10).
Discussion
In the current study, the role of TLRs in the response to
CHPV in RAW cells was examined. RAW 264.7 cells ex-
press various TLRs and have a high sensitivity to TLR
ligands [29]. We demonstrate that CHPV infection regu-
lates the TLR4 during infection in RAW cells and TLR4
and NO involved in disease pathogenesis in mice.
TLR4 is involved in LPS signaling and senses Gram
negative bacteria [30,31]. The role of TLR4 in LPS sig-
naling has been reviewed in detail elsewhere [32,33].
The first indication that TLR4 was involved in the re-
sponse to viral infection came from research on RSV
[34] and VSV [35]. We compared our results with avail-
able literature on vesicular stomatitis virus and other
viruses. In experimental HSV-1 infection in TLR2
knockout mice, it was reported that TLR2 mediated
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Figure 8 Level of proinflammatory cytokines (TNF-α, IFN-γ, MCP-1, IL-6, IL-10 and IL-12p70) in sera of C3H/HeJ and C3H/CaJ mice. At
various time points, three mice from both infected (inf) as well as control (con) mice were bled. The sera were separated and used for cytokine
quantification. The levels of TNF-α, MCP-1, IL-10, IL-6, IL-12 and IFN-γ in the undiluted sera were quantified using a BD™ Cytometric Bead Assay
mouse inflammation kit. The beads were acquired and analyzed using a FACSCalibur cell sorter and BD™ Cytometric Bead Array Software (BD
Bioscience). The level of cytokines was quantified using known standard supplied with kit. Values represent the mean ± SE of three mice.
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of the mice [36]. In our study, we used TLR4 mutant,
C3H/HeJ mice to demonstrate the role of TLR4 in dis-
ease pathogenesis. C3H/HeJ mice are highly resistant to
LPS, showing no usual biological effects, yet, they show
a normal response to other bacterial products and to
most cytokines induced by LPS. The LPS-resistant
phenotype results from defects in the gene for TLR4
(Tlr4) [30,31]. The percentage survival rate and mean
survival time was significantly higher in TLR4 mutant
C3H/HeJ mice as compared to those in wild type C3H/
CaJ mice. Initially, we suspect that a proinflammatory
cytokines level is associated with C3H/HeJ survival. In
order to confirm that six signature proinflammatory
cytokines in infected C3H/HeJ and C3H/CaJ mice were
quantified. Interestingly, the level of MCP-1 and IFN-γ
was significantly higher in CHPV infected C3H/HeJ
mice than those in infected C3H/CaJ mice.
The role of MCP-1 in protection against virus infec-
tion was well documented in influenza virus infection in
mice model [37]. The authors opined that lack of MCP-
1 responsible for increased virus load in virus infected
mice. In our different study, it was observed that high
level of MCP-1 in patients recovered from CHPV infec-
tion (data not shown). Similarly IFN-γ is reported to be
a critical antiviral mediator to eliminate the virus from
CNS [38]. IFN-γ treatment at early stage of influenza
virus infection protects mice from death [39]. IFN-γ ef-
fectively inhibits the replication of VSV in neuronal cells
[40]. These cytokines might contribute increase in sur-
vival rate in C3H/HeJ mice. These findings could be
verified by experimental animal model using MCP-1 and
IFN-γ deficient mice. In the current study, there was no
significant difference in the level of virus specific anti-
bodies between C3H/HeJ and C3H/CaJ mice which
eliminate the possibility of difference in level of anti-
bodies in protection against CHPV infection.
It was reported that IFN-γ treatment enhances the se-
cretion of NO in VSV infected neuronal cells which in-
hibit the virus replication [41]. In this study, we
demonstrate that CHPV infection in RAW cells induced
NO secretion. As the NO inhibits the virus replication,
it was thought that NO inhibitor (AG) treatment may
increase the severity of pathogenesis in infected mice.
Conversely, partial protection was observed in treated
mice. Thus, we concluded that NO may contribute to
the pathogenesis and mortality in infected mice.
Conclusions
Chandipura virus activates TLR4, which leads to the se-
cretion of proinflammatory cytokines and NO. Despite
activation of the innate immune system, mortality
observed in young mice. Partial protection in TLR4 mu-
tant mice and nitric oxide inhibitor treated wild-type
mice indicated that TLR4 and NO contributed in disease
pathogenesis. These results are significant in clinical
management and designing antiviral intervention.
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Figure 9 NO levels in culture supernatants of Chandipura virus-
infected RAW cells. RAW cells were infected with different MOI of
virus. The supernatants were collected at 24 h PI. The NO level in
the supernatants was measured using the Griess method. Values
represent the mean± SE of triplicate experiments.
Figure 10 Survival of virus-infected mice treated with the NO
inhibitor, AG. Young Swiss albino mice were infected with
Chandipura virus. One group of infected mice was treated with AG.
Non-AG-treated mice were used as a virus control. The treatment
was continued up to 120 h PI. Mortality was observed up to 240 h
PI. Percent survival was calculated using Kaplan-Meier statistics and
GraphPad Prism 5 software.
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